23 Jul, 2026
According to Straits Research, the global epilepsy surgery market size was valued at $1.25 billion in 2025 and is projected to grow from $1.32 billion in 2026 to $2.08 billion by 2034 at a CAGR of 5.82% during the forecast period 2026-2034.
Epilepsy is a chronic neurological condition marked by frequent, unwarranted seizures. Seizures in people with epilepsy frequently have unidentified causes. These seizures may have been brought on by a traumatic event or a prior brain injury, although their precise causes are still unknown. The disorder frequently affects adults and children, but the likelihood of infection is higher in the elderly population.
Invasive craniotomies are avoided using contemporary technology for surgical planning, navigation, and robotic guidance. The advantages of minimally invasive procedures are better patient outcomes, significantly lower complication rates, and shorter hospital stays. Stereoscopic electroencephalography (SEEG), biopsy, thermal ablation of seizure foci or tumors, Deep brain stimulation (DBS), and surgical treatment of movement disorders are becoming increasingly popular in epilepsy surgery.
Under the guidance of a noninvasive presurgical epilepsy workup, neurologists and neurosurgeons collaborate to develop a basic SEEG plan. In 2019, the US FDA authorized Zimmer Biomet to use the ROSA One Brain Application, a robotic surgical navigation and positioning system for neurosurgical procedures. As a result of the robot's speed and accuracy, which make it ideal for complex procedures in which numerous instruments are inserted into the brain, the company's ROSA Brain portfolio had a significant impact on epilepsy surgery. The epilepsy surgery market is growing more lucrative as hospitals and research facilities utilize robot-assisted surgery equipment more frequently.
Emerging markets are anticipated to offer growth opportunities for global market participants because of technological advancements, a growing elderly population at risk for seizure disorders, and government initiatives to fund research studies on epilepsy surgery. For instance, engineers at the So Carlos School of Engineering at the University of So Paulo in Brazil are developing a robot that will be used during surgeries on young patients with epilepsy. The researchers used a state-of-the-art, 1.6-meter-long, 45-kilogram articulated mechanical arm imported from Germany to create the new technology. To provide patients with well-regulated services of the highest caliber, market participants in the global epilepsy surgery market compete.
Businesses are also expanding to serve a larger geographic market. The producers are establishing a strategic alliance with leading hospitals and research institutions to supply the equipment required for surgery, maintain the products, and educate healthcare professionals. For instance, a study article published in October 2018 discussed the collaboration between healthcare professionals from the US and Vietnam traveling to Hanoi, Vietnam, using online communication platforms for case review and real-time mentoring to improve surgical care since 2015. Vietnam had conducted 40 pediatric epilepsy surgeries by 2017.
America is the most significant contributor to the global epilepsy surgery market and is expected to grow at a CAGR of 5.20% during the forecast period. The Americas have dominated the global market for epilepsy surgery as a result of several factors, including reputable medical facilities, the high prevalence of neurological disorders, and the rising incidence of epilepsy. Estimates state that 150,000 Americans have seizures due to the fourth most prevalent neurological disease, a condition of the central nervous system (CNS). Epilepsy is becoming more common among Americans. The highest incidence rates are in young children under two years old and adults 65 and older.
Europe is expected to grow at a CAGR of 6.12% during the forecast period. Due to rising research and development costs, the development of potent epilepsy medications, and a high prevalence of epilepsy disease, Europe has grown into a significant market for epilepsy surgery. In the coming years, the market for epilepsy surgery will grow thanks to the region's significant growth potential. According to the 2020 EU Industrial Research and Development Scoreboard, businesses in the European Union have increased their investments in R&D. Businesses in Europe made 5.6% more R&D investments in 2019 compared to 2018. The market in the area is expanding due to the European Commission's approval of more medications for the management of epilepsy.
sales@straitsresearch.com